Contents: Deep Dive – Access and Commercialisation

Access and Commercialisation
Cover

Access and Commercialisation

Click here

Access and Commercialisation Introduction
Introduction

Welcome from the Editor

Click here

Andre Heeg
Developing with start-up DNA

Sandoz’s head of digital André Heeg spoke to us about how he uses his experience from start-ups to find new ways to harness digital

Click here

China in the fast lane
China in the fast lane

Brett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest emerging market

Click here

NHS England gets commercial
NHS England gets commercial

Leela Barham considers NHS England’s role and influence when it comes to access to medicines and looks at what the Commercial Framework could include

Click here

The pharma world at your fingertips
The pharma world at your fingertips

Daily News from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

ICON
US healthcare reform scenarios: how might the current system be impacted?

ICON’s Pricing and Market Access team conducted interviews with formulary decision makers to analyse potential outcomes for US healthcare

Click here

Kris Sterkens
Time to fix pharma’s outdated business model

We spoke to Kris Sterkens, Janssen’s company group chairman EMEA, about the challenges facing big pharma and the increasing importance of engaging with patients

Click here

IDEA pharma
The future of R&D innovation

Alexander Gray and Mike Rea from IDEA Pharma explain why the current pharma R&D model is broken, and how it’s hindering commercialisation across the industry

Click here

Innovation Lab
Under the skin of innovation

We caught up with LEO Innovation Lab’s John Zibert to learn more about the philosophy behind the Lab and how he sees the future of digital in pharma

Click here

Get future editions of Deep Dive
Forthcoming issues of Deep Dive

Sign up to receive complimentary editions of the magazine direct to your inbox, including the forthcoming Oncology issue

Click here

Impetus Digital
How digital could transform stakeholder engagement

Natalie Yeadon from Impetus Digital on how asynchronous stakeholder engagement platforms can bring real transformation to the industry

Click here

Bringing gene therapies to market
Bringing gene therapies to market

Doug Danison from bluebird bio on the obstacles, opportunities and required change in thinking needed to ensure patients have access to innovative personalised medicines

Click here

Deep Dive Contacts
Deep Dive – contact us

How to get in touch with the magazine’s editorial, commercial and design teams

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Your name

Your e-mail

Your message

Send